Article
Supercharging CAR-T cells through transcriptional and epigenetic armoring
18 Feb 2025
Abstract excerpt
Inspired by the remarkable success of CAR-T therapy in hematologic malignancies, research is increasingly focused on adapting this treatment for solid tumors. However, CAR-T efficacy remains limited due to its exhaustion and shortened persistence. Transcription factors and epigenetic modifications play pivotal roles in modulating T cell differentiation and functionality, which have been leveraged in numerous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
